U. Manne et al., Nuclear accumulation of p53 in colorectal adenocarcinoma - Prognostic importance differs with race and location of the tumor, CANCER, 83(12), 1998, pp. 2456-2467
BACKGROUND, Although several studies have been conducted to examine the rol
e of p53 genetic abnormalities and their prognostic value in colorectal car
cinoma, the incidence of nuclear accumulation of p53 and the prognostic imp
ortance of nuclear accumulation of p53 in African-American and white patien
ts have not been investigated separately. Therefore, the authors evaluated
the prognostic significance of p53 nuclear accumulation in these two racial
groups.
METHODS. Nuclear accumulation of p53 was evaluated immunohistochemically in
archival tissue specimens from 204 African-American and 300 white patients
with primary colorectal adenocarcinomas who had undergone surgery. Surviva
l times from colorectal adenocarcinoma were analyzed using Kaplan-Meier sur
vival estimates and the Cox proportional hazards model for nuclear accumula
tion of p53 with adjustments for other confounding demographic and clinical
variables.
RESULTS, Approximately equivalent proportions of distal (54%) and proximal
adenocarcinomas (47%) were positive for nuclear accumulation of p53 in Afri
can-American patients. In contrast, distal colorectal adenocarcinomas from
white patients more frequently were positive for nuclear accumulation of p5
3 than adenocarcinomas of the proximal colon (63% vs. 38%, respectively). N
uclear ac cumulation of p53 was found to be a strong predictor of poor surv
ival in white patients (hazard ratio = 6.77; P = 0.0001) but not in African
-American patients with primary adenocarcinomas of the proximal colon. Nucl
ear accumulation of p53 was not of prognostic value in patients of either r
ace with primary adenocarcinomas of the distal colorectum.
CONCLUSIONS. Nuclear accumulation of p53 is a valuable indicator of poor pr
ognosis only for white patients with adenocarcinomas of the proximal colon.
The current study also suggests that the role of p53 dysregulation in colo
rectal adenocarcinomas may vary with the anatomic location of the tumor and
the race of the patient. These findings suggest that the demographic chara
cteristics of patients should be considered in the evaluation of prognostic
markers of colorectal neoplasia. Cancer 1998;83:2456-67, (C) 1998 American
Cancer, Society.